Acasti Pharma
ACST
$2.78
Share price
3.73%
Change (1 day)
504.35%
Change (1 year)
Categories
Revenue for Acasti Pharma (ACST)
Revenue in 2023 (TTM): N/A
a decrease over the years 2022 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Acasti Pharma from 2010 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2023  | N/A | |
| 2022 | N/A | -100% |
| 2021 | $0.11 M | 41.98% |
| 2020 | $0.08 M | |
| 2018 | N/A | |
| 2016 | $0.01 M | -90.72% |
| 2015 | $0.11 M | -47.54% |
| 2014 | $0.22 M | -24.12% |
| 2013 | $0.29 M | -57.39% |
| 2012 | $0.69 M | 498.81% |
| 2011 | $0.11 M | |
| 2010 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | N/A | N/A | 🇺🇸 USA |